Compare
Booz Allen Hamilton Holding Corp vs Genpact Ltd vs ICF International, Inc. vs Exponent Inc
| Latest fiscal year | Booz Allen Hamilton Holding Corp BAH | Genpact Ltd G | ICF International, Inc. ICFI | Exponent Inc EXPO |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2025-12-31 | 2026-01-02 |
| Revenue | $11.22B | $5.08B | $1.87B | $582.01M |
| Revenue growth (YoY) | -6.4% | +6.6% | -7.3% | +4.2% |
| Gross margin | 52.7% (computed) | 36.0% | 37.2% (computed) | n/a |
| Operating margin | 9.2% | 14.8% | 7.8% | 20.6% |
| Net margin | 7.6% | 10.9% | 4.9% | 18.2% |
| Net income | $851.00M | $552.49M | $91.59M | $106.01M |
| EPS (Diluted) | $6.90 | $3.13 | $4.95 | $2.07 |
| Operating cash flow | $1.04B | $812.86M | $141.87M | $131.73M |
| Free cash flow | $951.00M | $734.65M | $120.21M | $122.34M |
| Cash & equivalents | $728.00M | $853.84M | $5.30M | $221.93M |
| Total assets | $7.12B | $5.84B | $2.05B | $777.52M |
| Total liabilities | $6.01B | $3.29B | $1.02B | $387.18M |
| Shareholders' equity | $1.10B | $2.55B | $1.03B | $390.34M |
| Return on year-end equity | 77.0% | 21.7% | 8.9% | 27.2% |
| Shares outstanding | 120.34M | 170.34M | 18.25M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Booz Allen Hamilton Holding Corp | Genpact Ltd | ICF International, Inc. | Exponent Inc |
|---|---|---|---|---|
| Latest | $11.22B Ended 2026-03-31 | $5.08B Ended 2025-12-31 | $1.87B Ended 2025-12-31 | $582.01M Ended 2026-01-02 |
| 1 year earlier | $11.98B Ended 2025-03-31 | $4.77B Ended 2024-12-31 | $2.02B Ended 2024-12-31 | $558.51M Ended 2025-01-03 |
| 2 years earlier | $10.66B Ended 2024-03-31 | $4.48B Ended 2023-12-31 | $1.96B Ended 2023-12-31 | $536.77M Ended 2023-12-29 |
| 3 years earlier | $9.26B Ended 2023-03-31 | $4.37B Ended 2022-12-31 | $1.78B Ended 2022-12-31 | $513.29M Ended 2022-12-30 |
| 4 years earlier | $8.36B Ended 2022-03-31 | $4.02B Ended 2021-12-31 | $1.55B Ended 2021-12-31 | $466.27M Ended 2021-12-31 |